|
01/17/2025 07:00 AM EST
BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), have agreed to pay $704,349 to resolve alleged violations of the False Claims Act arising from BioReference's submission of claims for laboratory tests that had not been ordered by a patient's provider. OPKO is a Delaware Corporation. BioReference, a subsidiary of OPKO, is headquartered in New Jersey and is one of the largest clinical laboratories in the United States.
01/17/2025 07:00 AM EST
The Justice Department issued the following statements from Attorney General Merrick B. Garland and Deputy Attorney General Lisa Monaco on the Supreme Court's decision in TikTok, et al. v. Garland:
No comments:
Post a Comment